Shawn M. Ellerbroek
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Shawn M. Ellerbroek has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
Janean Farley
A Department of BCES , Wartburg College , Waverly , IA , USA
2 shared publications- Kris A. DeMali
Roy J. and Lucille A. Carver College of Medicine at the University of Iowa, Department of Biochemistry and Molecular Biology, 51 Newton RD, Iowa City, IA 52242, USA
2 shared publications Aaron Kotecki
1 shared publicationAditi Patel
A Department of BCES , Wartburg College , Waverly , IA , USA
1 shared publicationAlexandra Carolan
1 shared publicationAmy Kobliska
1 shared publication
Latest Publications
- Open Access
- 24 February 2026
- Published by Wiley in FEBS Open Bio
- Vol. 16 (7) , 1414-1427
Matrix metalloproteinase‐9 regulates cell adhesion and membrane protrusive activity of ovarian cancer cells
Matrix metalloproteinase‐9 (MMP9), an extracellular endopeptidase, is upregulated by Epidermal Growth Factor (EGF) signaling and associated with ovarian epithelial cancer progression. To further understand the contribution of MMP9 to EGF‐stimulated metastatic behavior, we created MMP9‐null cells (M9‐KO) from an ovarian cancer cell line. This model showed MMP9 loss did not block EGF‐driven E‐cadherin dissolution and associated epithelial‐to‐mesenchymal transition. However, MMP9‐null cells exhibited delayed and reduced EGF‐driven actin‐based membrane protrusions, with transient re‐expression of MMP9 sufficient to drive both lamellipodial and filopodial membrane protrusions. Finally, M9‐KO cells exhibited a reduction of adhesion to extracellular matrices, which was significantly recovered by stable re‐expression of MMP9. Together, these results provide direct evidence that MMP9 mediates EGF‐driven membrane protrusions and promotes ovarian cancer cell adhesion to mesothelial extracellular matrices. Impact statement: This work provides direct evidence that MMP9 mediates EGF‐driven membrane protrusions and promotes ovarian cancer cell adhesion to mesothelial extracellular matrices.
- 24 February 2026
- Published by Wiley in FEBS Open Bio
- Vol. 16 (7) , 1414-1427
Open AccessMatrix metalloproteinase‐9 regulates cell adhesion and membrane protrusive activity of ovarian cancer cells
Matrix metalloproteinase‐9 (MMP9), an extracellular endopeptidase, is upregulated by Epidermal Growth Factor (EGF) signaling and associated with ovarian epithelial cancer progression. To further understand the contribution of MMP9 to EGF‐stimulated metastatic behavior, we created MMP9‐null cells (M9‐KO) from an ovarian cancer cell line. This model showed MMP9 loss did not block EGF‐driven E‐cadherin dissolution and associated epithelial‐to‐mesenchymal transition. However, MMP9‐null cells exhibited delayed and reduced EGF‐driven actin‐based membrane protrusions, with transient re‐expression of MMP9 sufficient to drive both lamellipodial and filopodial membrane protrusions. Finally, M9‐KO cells exhibited a reduction of adhesion to extracellular matrices, which was significantly recovered by stable re‐expression of MMP9. Together, these results provide direct evidence that MMP9 mediates EGF‐driven membrane protrusions and promotes ovarian cancer cell adhesion to mesothelial extracellular matrices. Impact statement: This work provides direct evidence that MMP9 mediates EGF‐driven membrane protrusions and promotes ovarian cancer cell adhesion to mesothelial extracellular matrices.
- Open Access
- 29 June 2016
- Published by Taylor & Francis in Small GTPases
- Vol. 8 (2) , 114-121
Arg188 drives RhoC membrane binding
RhoA and RhoC GTPases are 92% identical but demonstrate unique regulation and function. Phosphorylation of Ser188 has widely been reported to inhibit RhoA activity. RhoC possesses Arg188 in place of Ser188 but retains a canonical upstream PKA recognition sequence. We report here that RhoC-R188S was a PKA substrate in vitro and exhibited less GTP loading compared to wild-type RhoC when expressed in cells. Transiently expressed RhoC was found to be significantly more membrane associated than RhoA. Membrane association of RhoC-R188S and RhoC-R188A were similar to each other and wild-type RhoA, suggesting that Arg188 directly promotes RhoC membrane binding. The positive influence of Arg188 on RhoC membrane association was evident in a constitutively active (Q63L) background. In accordance, RhoA-S188R was significantly more membrane associated than either RhoA or RhoA-S188A. Altogether, these data suggest that swapping residue 188 identity effectively flips the membrane binding profile of wild-type RhoA and RhoC through positive arginine contribution rather than negative phosphoserine regulation.
- 29 June 2016
- Published by Taylor & Francis in Small GTPases
- Vol. 8 (2) , 114-121
Open AccessArg188 drives RhoC membrane binding
RhoA and RhoC GTPases are 92% identical but demonstrate unique regulation and function. Phosphorylation of Ser188 has widely been reported to inhibit RhoA activity. RhoC possesses Arg188 in place of Ser188 but retains a canonical upstream PKA recognition sequence. We report here that RhoC-R188S was a PKA substrate in vitro and exhibited less GTP loading compared to wild-type RhoC when expressed in cells. Transiently expressed RhoC was found to be significantly more membrane associated than RhoA. Membrane association of RhoC-R188S and RhoC-R188A were similar to each other and wild-type RhoA, suggesting that Arg188 directly promotes RhoC membrane binding. The positive influence of Arg188 on RhoC membrane association was evident in a constitutively active (Q63L) background. In accordance, RhoA-S188R was significantly more membrane associated than either RhoA or RhoA-S188A. Altogether, these data suggest that swapping residue 188 identity effectively flips the membrane binding profile of wild-type RhoA and RhoC through positive arginine contribution rather than negative phosphoserine regulation.
- 1 October 2015
- Vol. 35 (10) , 5263-70
Lysophosphatidic Acid Stimulates Urokinase Receptor (uPAR/CD87) in Ovarian Epithelial Cancer Cells.
Lysophosphatidic acid (LPA) is a bioactive lipid positively linked with ovarian cancer progression. The multi-functional urokinase receptor (uPAR), a cell-surface glycoprotein, binds and facilitates activation of uPA and laterally regulates integrin and tyrosine kinase receptor activities in promotion of cell migration and invasion. We hypothesized that LPA stimulates uPAR expression and activity in ovarian epithelial cancer cells. Ovarian epithelial cancer cell lines OVCA 429 and OVCA 433 were stimulated with LPA and examined for uPAR mRNA expression and protein localization. uPA binding to OVCA plasma membranes was measured through enzymatic analysis of affinity-isolated cell-surface proteins. LPA drove cell-surface uPAR aggregation and mRNA expression concomitant with increased cell-surface binding of uPA. Both control and LPA-stimulated uPAR expression and uPA cell-surface association involved phosphatidylinositol 3-kinase, but not p38 or p42 mitogen-activated protein kinase, signaling. These data provide mechanistic insight into ovarian epithelial cancer cell progression by demonstrating that LPA drives uPAR expression and uPA binding.
- 1 October 2015
- Vol. 35 (10) , 5263-70
Lysophosphatidic Acid Stimulates Urokinase Receptor (uPAR/CD87) in Ovarian Epithelial Cancer Cells.
Lysophosphatidic acid (LPA) is a bioactive lipid positively linked with ovarian cancer progression. The multi-functional urokinase receptor (uPAR), a cell-surface glycoprotein, binds and facilitates activation of uPA and laterally regulates integrin and tyrosine kinase receptor activities in promotion of cell migration and invasion. We hypothesized that LPA stimulates uPAR expression and activity in ovarian epithelial cancer cells. Ovarian epithelial cancer cell lines OVCA 429 and OVCA 433 were stimulated with LPA and examined for uPAR mRNA expression and protein localization. uPA binding to OVCA plasma membranes was measured through enzymatic analysis of affinity-isolated cell-surface proteins. LPA drove cell-surface uPAR aggregation and mRNA expression concomitant with increased cell-surface binding of uPA. Both control and LPA-stimulated uPAR expression and uPA cell-surface association involved phosphatidylinositol 3-kinase, but not p38 or p42 mitogen-activated protein kinase, signaling. These data provide mechanistic insight into ovarian epithelial cancer cell progression by demonstrating that LPA drives uPAR expression and uPA binding.
- Open Access
- 1 January 2012
- Published by Taylor & Francis in Small GTPases
- Vol. 3 (1) , 15-22
Divergence of Rho residue 43 impacts GEF activity
RhoA, RhoB and RhoC GTPases are over 85% identical at the amino acid level, with RhoA and RhoC differing at only one residue (43) across the initial two-thirds of their sequences. A putative regula...
- 1 January 2012
- Published by Taylor & Francis in Small GTPases
- Vol. 3 (1) , 15-22
Open AccessDivergence of Rho residue 43 impacts GEF activity
RhoA, RhoB and RhoC GTPases are over 85% identical at the amino acid level, with RhoA and RhoC differing at only one residue (43) across the initial two-thirds of their sequences. A putative regula...
- Open Access
- 1 July 2004
- Published by American Society for Cell Biology (ASCB) in Molecular Biology of the Cell
- Vol. 15 (7) , 3309-3319
SGEF, a RhoG Guanine Nucleotide Exchange Factor that Stimulates Macropinocytosis
SGEF (SH3-containing Guanine Nucleotide Exchange Factor) is a RhoGEF of unknown function. We found the SGEF protein to be expressed in many established cell lines and highly expressed in human liver tissue. SGEF stimulated the formation of large interconnected membrane ruffles across dorsal surfaces when expressed in fibroblasts. SGEF required its proline-rich amino-terminus to generate dorsal, but not lateral, membrane ruffles and a functional SH3 domain to colocalize with filamentous actin at sites of membrane protrusion. Full-length SGEF activated RhoG, but not Rac, when expressed in fibroblasts. Further, recombinant SGEF DH/PH protein exchanged nucleotide on RhoG, but not on Rac1 or Rac3, in vitro. Scanning electron microscopy of fibroblasts demonstrated that SGEF induced dorsal ruffles that were morphologically similar to those generated by constitutively active RhoG, but not constitutively active Rac1. Transient expression of SGEF stimulated fibroblast uptake of 10-kDa dextran, a marker of macropinocytosis. This required the full-length protein and a catalytically active DH domain. Finally, activated RhoG was found to be more effective than activated Rac, and comparable to SGEF, in its ability to trigger dextran uptake. Together, this work establishes SGEF as a RhoG exchange factor and provides evidence that both SGEF and RhoG regulate membrane dynamics in promotion of macropinocytosis.
- 1 July 2004
- Published by American Society for Cell Biology (ASCB) in Molecular Biology of the Cell
- Vol. 15 (7) , 3309-3319
Open AccessSGEF, a RhoG Guanine Nucleotide Exchange Factor that Stimulates Macropinocytosis
SGEF (SH3-containing Guanine Nucleotide Exchange Factor) is a RhoGEF of unknown function. We found the SGEF protein to be expressed in many established cell lines and highly expressed in human liver tissue. SGEF stimulated the formation of large interconnected membrane ruffles across dorsal surfaces when expressed in fibroblasts. SGEF required its proline-rich amino-terminus to generate dorsal, but not lateral, membrane ruffles and a functional SH3 domain to colocalize with filamentous actin at sites of membrane protrusion. Full-length SGEF activated RhoG, but not Rac, when expressed in fibroblasts. Further, recombinant SGEF DH/PH protein exchanged nucleotide on RhoG, but not on Rac1 or Rac3, in vitro. Scanning electron microscopy of fibroblasts demonstrated that SGEF induced dorsal ruffles that were morphologically similar to those generated by constitutively active RhoG, but not constitutively active Rac1. Transient expression of SGEF stimulated fibroblast uptake of 10-kDa dextran, a marker of macropinocytosis. This required the full-length protein and a catalytically active DH domain. Finally, activated RhoG was found to be more effective than activated Rac, and comparable to SGEF, in its ability to trigger dextran uptake. Together, this work establishes SGEF as a RhoG exchange factor and provides evidence that both SGEF and RhoG regulate membrane dynamics in promotion of macropinocytosis.